Related Experiment Videos
Rheumatoid symptoms following breast cancer treatment: a controlled comparison
M A Andrykowski1, S L Curran, J S Carpenter
1Department of Behavioral Science, University of Kentucky College of Medicine, Lexington 40536-0086, USA.
Journal of Pain and Symptom Management
|September 15, 1999
Summary
Breast cancer survivors frequently experience rheumatoid symptoms like joint pain and stiffness. These symptoms appear linked to surgical treatment, not chemotherapy, impacting quality of life.
Area of Science:
- Oncology
- Rheumatology
- Quality of Life Research
Background:
- Rheumatoid symptoms are a potential concern for breast cancer survivors.
- The link between breast cancer treatment and subsequent rheumatoid symptoms requires further investigation.
Purpose of the Study:
- To examine the prevalence of rheumatoid symptoms in breast cancer survivors.
- To explore potential associations between breast cancer treatment modalities and rheumatoid symptoms.
- To assess the impact of rheumatoid symptoms on quality of life in breast cancer patients.
Main Methods:
- A self-report measure was administered to 111 breast cancer patients and 99 women with benign breast problems.
- Participants assessed joint pain, swelling, stiffness, and quality of life.
- Data analysis compared symptom prevalence and characteristics between the breast cancer and benign breast problem groups.
Main Results:
- Breast cancer patients reported significantly more joint stiffness, particularly morning stiffness lasting over 60 minutes.
- Increased prevalence of joint pain and swelling, especially in upper extremities, was observed in the breast cancer group.
- 41% of breast cancer survivors reported their current rheumatoid symptoms were worse than before diagnosis, with surgical management implicated over chemotherapy.
Conclusions:
- Breast cancer treatment, particularly surgery, is associated with an increased prevalence of rheumatoid symptoms.
- Rheumatoid symptoms significantly impact the quality of life for breast cancer survivors.
- Further research is warranted to explore contributing factors like menopausal status, lymphedema, and weight gain.